Tivity Health — Healthways — Proxy Contest (May 2014)
69 slides from Tivity Health's proxy contest presentation, May 30, 2014
Slide 1: Healthways: Presentation to Healthways Shareholders - The Need for Change
HEALTHWAYS: Presentation to Healthways Shareholders THE NEED FOR CHANGE May 30, 2014
Slide 2: Disclaimer
DISCLAIMER THIS PRESENTATION IS FOR DISCUSSION AND GENERAL INFORMATIONAL PURPOSES ONLY. IT DOES NOT HAVE REGARD TO THE SPECIFIC INVESTMENT OBJECTIVE, FINANCIAL SITUATION, SUITABILITY, OR THE PARTICULAR NEED OF ANY SPECIFIC PERSON WHO MAY RECEIVE THIS PRESENTATION, AND SHOULD NOT BE TAKEN AS ADVICE O
Slide 3: Introduction
INTRODUCTION N o r t h T i d e C a p i t a l i s s e e k i n g t o r e p l a c e f o u r ( 4 ) d i r e c t o r s a t H e a l t h w ay s , I n c . ( “ H e a l t h w ay s ” o r t h e “ C o m p a ny ” ) a t t h e C o m p a ny ’ s 2 01 4 A n n u a l m e e t i n g t o b e h e l d o n J u n e 24 , 2 01 4
Slide 4: About North Tide Capital
ABOUT NORTH TIDE CAPITAL Nor th Tide Capital, LLC (“North Tide”) is one of the largest shareholders of Healthways and currently owns 3,850,000 shares, representing approximately 11% of the Company We are a $1 .35B va lue-oriented investment firm based in Boston, M A with a dedicated focus on the
Slide 5: How We Got Here
HOW WE GOT HERE W h e n w e m a d e o u r i n i t i a l i n v e s t m e n t i n H e a l t h w ay s i n 2 01 1 , w e “ k n e w w h a t w e w e r e getting” in terms of the management team and its track record, but we gave management the benefit of the doubt that the opportunity was so significant i
Slide 6: Our Objectives Are Clear
OUR OBJECTIVES ARE CLEAR T h i s e l e c t i o n i s a b o u t r e p la c i n g f o u r i n c u m b e n t d i r e c to r s w h o h a v e n o r e l e v a n t h e a l t h c a r e e x p e r i e n c e , w i t h a h i g h l y q u a l if i e d t e a m w h o h a v e s i g n i fi c a n t r e l e v a n t h
Slide 7: Part I: The Track Record of Value Destruction
PART I: THE TRACK RECORD OF VALUE DESTRUCTION 7
Slide 8: The Value Destruction from the Current Team and Strategy Is Irrefutable
THE VALUE DESTRUCTION FROM THE CURRENT TEAM AND STRATEGY IS IRREFUTABLE We b elieve Healthways’ p e r formance record has been abysmal on almost any metric over the past decade, and the Board has done nothing to acknowledge or correct the situation We b e l i ev e H e a l t h w ay s ’ s h a r e s
Slide 9: Total Shareholder Return Has Been Horrific Over the Past Ten Years
WE BELIEVE TOTAL SHAREHOLDER RETURN (TSR) HAS BEEN HORRIFIC OVER THE PAST TEN YEARS 250% 200% 150% +127% 100% +107% 50% 0% Oct-03 Feb-04 Jun-04 Oct-04 Feb-05 Jun-05 Oct-05 Feb-06 Jun-06 Oct-06 Feb-07 Jun-07 Oct-07 Feb-08 Jun-08 Oct-08 Feb-09 Jun-09 Oct-09 Feb-10 Jun-10 Oct-10 Feb-11 Jun-11 Oct-11 Fe
Slide 10: TSR Has Been Abysmal Over Almost Any Measuring Period
WE BELIEVE TSR HAS BEEN ABYSMAL OVER ALMOST ANY MEASURING PERIOD One year Three year 140% 120% 120% 100% 100% 80% +80% 80% 60% +59% 60% +35% 40% 40% 20% +9% 20% +27% 0% +17% 0% Oct-10 10 Feb-11 11 Jun-11 11 Oct-11 11 Feb-12 12 Jun-12 12 Oct-12 12 Feb-13 13 Jun-13 13 -20% Feb-13 Apr-13 Jun-13 Oct-12
Slide 11: HWAY Shares Have Also Significantly Underperformed Versus Peers
HWAY SHARES HAVE ALSO SIGNIFICANTLY UNDERPERFORMED VERSUS PEERS Stock price perf ormance through 10/28/13 Last Last Last Last Last Last ten yrs f ive yrs f our yrs three yrs two yrs 12 mos YTD 2013 S&P 500 Index 68% 87% 69% 49% 37% 25% 20% S&P Healthcare Index 87% 98% 87% 69% 55% 31% 30% (1) Peer av
Slide 12: EBITDA Declined 64% Over the Last 5 Years, and 52% Over the Last 2
EBITDA DECLINED 64% OVER THE LAST 5 YEARS, AND 52% OVER THE LAST 2 YEARS $800 30% $700 25% $600 20% $500 $400 15% $300 10% $200 5% $100 $0 0% 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Revenue EBITDA EBITDA margin % Note: Dollar figures in millions. Healthways reported figures for a fisc
Slide 13: EPS Decline Has Been Precipitous
EPS DECLINE HAS BEEN PRECIPITOUS $1.60 $1.40 $1.20 $1.00 $0.80 $0.60 $0.40 $0.20 $0.00 ($0.20) ($0.40) Note: Dollar figures in millions. Healthways reported figures for a fiscal year end of 8/31 through 2007 and a fiscal year end of 12/31 in subsequent years. In order to enhance comparability betwee
Slide 14: The Company Is Dangerously Close to Violating Its Debt Covenants
THE COMPANY IS DANGEROUSLY CLOSE TO VIOLATING ITS DEBT COVENANTS Despite having continuously modified the coverage levels under its debt covenants, Healthways remains dangerously close to violating these levels F2012A F2013A F2014E 1QA 2QA 3QA 4QA 1QA 2QA 3QA 4QA 1QA 2QE 3QE 4QE Mar-12 Jun-12 Sep-12
Slide 15: Management and the Board Have Been Terrible Stewards of Capital
WE BELIEVE MANAGEMENT AND THE BOARD HAVE BEEN TERRIBLE STEWARDS OF CAPITAL Over the last 10 years under the current leader ship: H e a l t h w ay s h a s s p e n t $ 1 . 0 2 b n o n c a p i t a l e x p e n d i t u r e s a n d a c q u i s i t i o n s t o g e n e r a t e c u m u l a t i v e E B I T
Slide 16: Management Has Missed Its Internal Targets in Six Out of the Past Ten Years
MANAGEMENT HAS MISSED ITS INTERNAL TARGETS IN SIX OUT OF THE PAST TEN YEARS Year Target Actual Comment in prox y "Mr. Leedle did not receive an Annual Incentive Compensation plan award for fiscal 20 04 because the Company did no t 2004 Not disclosed $0.75 achieve certain internal revenue and earning
Slide 17: Management Turnover Below the CEO Level Has Been Constant
MANAGEMENT TURNOVER BELOW THE CEO LEVEL HAS BEEN CONSTANT There have been four (4) COOs over the past ten (10) years, with the longest tenure at three (3) years Donald Taylor, 2003-2005 James Pope, 2006-2008 Stefen Brueckner, 2009-2010 Thomas Cox, 2011-2012 There has been no COO since Thomas
Slide 18: Part II: The Performance of the Core Business Has Gotten Worse
PART II: THE PERFORMANCE OF THE “CORE” BUSINESS HAS GOTTEN WORSE
Slide 19: How the Core Business Has Performed During the Strategic Transformation
HERE’S HOW WE BELIEVE THE CORE BUSINESS HAS PERFORMED DURING THE “STRATEGIC TRANSFORMATION” $700 30% 25% $600 20% $500 15% $400 10% $300 5% 0% $200 -5% $100 -10% $0 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 -15% -$100 -20% Revenue EBITDA EBITDA margin % Note: Dollar figures in millions.
Slide 20: The Deterioration Is as Much a Spending Problem as a Revenue Problem
WE BELIEVE THE DETERIORATION IS AS MUCH A SPENDING PROBLEM AS A REVENUE PROBLEM Healthways provides almost no transparency into its business segments for investors to t ruly understand what’s working and what’s not, or evaluate management’s capital allocation decisions Healthways only recently s
Slide 21: Simply Turning Off the Spigot Could Be Significantly Additive to EBITDA
SIMPLY TURNING OFF THE SPIGOT COULD BE SIGNIFICANTLY ADDITIVE TO EBITDA , NOT HARM THE “LEGACY” BUSINESS We e s t i m a te t h a t s i m p l y g e t t i n g t h e c o r e b u s in e s s t o b r e a ke v e n w o u l d a d d u p t o $ 5 6 M M t o c o n s o l i d a te d i n E B I T DA We s u s p e
Slide 22: The Scale of the Legacy Business Suggests the Company Does Some Really Good Things
THE SCALE OF THE “LEGACY” BUSINESS SUGGESTS THE COMPANY DOES SOME REALLY GOOD THINGS We estimate the core US business, ex-Silver Sneakers, generates approximately $350MM in revenue today, and we suspect that the products and services highlighted in the Company’s “strategic transformation” represen
Slide 23: Part III: Challenging the Strategic Transformation
PART III: CHALLENGING THE “STRATEGIC TRANSFORMATION”
Slide 24: Opening Thoughts
OPENING THOUGHTS We have been investors in Healthways since 2011 and were not aware of a “strategic t ransformation” initiative until it was highlighted in the Company’s Investor Presentation filed with the SEC on M ay 8, 2014 We were not mistaken – a word search of SEC filings over the last fiv
Slide 25: Opening Thoughts (Cont'd)
OPENING THOUGHTS (CONT’D) Through its “strategic t ransformation” Healthways has aggregated a por tfolio of internally developed and third par ty concepts and programs that heretofore have had no commercial application, and is a t tempting to repackage these “ideas” into “well-being solutions” for
Slide 26: Healthways' So-Called Transformative Investments in Infrastructure
HEALTHWAYS’ SO-CALLED “TRANSFORMATIVE INVESTMENTS IN INFRASTRUCTURE” MeYou Blue Zones Ornish Dave Ramsey Innergy Health Mobile, social, Lifestyle pledges Lifestyle Financial advice Weight loss games management Gallup The Gallup-Healthways Well-Being Index Hewlett Packard Technology Platform 26
Slide 27: What Are These Things?
WHAT ARE THESE THINGS?
Slide 28: Gallup-Healthways Well-Being Index
GALLUP-HEALTHWAYS WELL-BEING INDEX HTTP://INFO.HEALTHWAYS.COM/WBI2013 The foundational piece of the “strategic transformation” appears to be Healthways’ partnership with Gallup to create the Gallup- Healthways Well-Being Index. We do not understand why customers would pay for this, but here is an ov
Slide 29: Gallup-Healthways Well-Being Index
GALLUP-HEALTHWAYS WELL-BEING INDEX HTTP://INFO.HEALTHWAYS.COM/WBI2013 We struggle to understand how the questions asked in the s u r vey help Healthways with “predictive modeling” to “stratify those pa r t icipants who are most a t risk for an adverse health event,” (2) much less create va lue for
Slide 30: MeYou Health
MEYOU HEALTH WWW.MEYOUHEALTH.COM MeYou Health is a Healthways subsidiar y based in Boston, MA with at least 37 employees “dedicated to helping people pursue, achieve and maintain a more healthful life by improving their well-being ever y day.” Here are MeYou Health’s three current of ferings: “The D
Slide 31: MeYou Health
MEYOU HEALTH WWW.MEYOUHEALTH.COM Here are four (4) of the twelve (12) MeYou Health projects that have failed so far, all funded by shareholder capital: Case: Small Action Man Case: Around the World Case: Super Friends Case: EveryDRINK Purpose: “Highlight the importance Purpose: “Explore the concepts
Slide 32: MeYou Health Appears to Be a Freemium Product
MEYOU HEALTH APPEARS TO BE A “FREEMIUM” PRODUCT “ We of fer a freemium product, Daily Challenge, which is available to individual user s and also with premium content to employer s. It’s our ‘open-social’ platform that enables user s in the employee setting to connect (and sometimes even have health
Slide 33: The Blue Zones Project
THE BLUE ZONES PROJECT WWW.BLUEZONESPROJECT.COM T h e B l u e Z o n e s P r o j e c t i s H e a l t h w ay s’ w e l l - b e i n g p r o d u c t b a s e d o n a b o o k by D a n B u e t t n e r, w h i c h i d e n t i f i e s l e s s o n s l e a r n e d i n c e r t a i n areas of the world where a h
Slide 34: Dr. Dean Ornish
DR. DEAN ORNISH H T T P : / / W W W. H E A LT H WAY S . C O M / S O L U T I O N / O R N I S H . A S P X ? I D = 1 1 2 0 In July 2013, Healthways signed an exclusive partnership with Dean Ornish, M.D., to “operate and license his Lifestyle Management Programs.” The Dean Ornish program is a lifest
Slide 35: Dr. Dean Ornish
DR. DEAN ORNISH H T T P : / / W W W. H E A LT H WAY S . C O M / S O L U T I O N / O R N I S H . A S P X ? I D = 1 1 2 0 “On July 15, 2013, we entered into an exclusive par tnership with Dean Ornish, M.D., to operate and license his Lifestyle Management Programs. In par tial consideration for this ex
Slide 36: Dave Ramsey Partnership
DAVE RAMSEY PARTNERSHIP WWW.DAVERAMSEY.COM The Dave Ramsey par tnership (also based on a book) is a program to improve a person’s “financial well being” “ F o r D a v e R a m s e y, i n c o r e f i n a n c i a l , w h e n y o u look at 73% of Americans living paycheck to paycheck, should be no surpr
Slide 37: Innergy
INNERGY Not much is disclosed about the Innergy program beyond that it appears to be primarily a one on one telephonic coaching program for weight loss, a market where established engagement models like Weight Watchers are struggling to compete with free Apps Healthways shareholders deserve to under
Slide 38: Healthways Is on Pace to Spend Almost $300 Million Over the Next 7 Years with HP
HEALTHWAYS IS ON PACE TO SPEND ALMOST $300 MILLION OVER THE NEXT 7 YEARS WITH HP “In May 2011, we entered into a ten-year applications and technology ser vices outsourcing agreement with HP Enterprise Ser vices, LLC that contains minimum fee requirements. Total payments over the remaining term…must
Slide 39: Part IV: This Is Not the First Time Healthways Has Said Trust Us
PART IV: THIS IS NOT THE FIRST TIME HEALTHWAYS HAS SAID “TRUST US”
Slide 40: Healthways Claims to Be at an Inflection Point in Growth and Margins
HEALTHWAYS CLAIMS TO BE AT AN INFLECTION POINT IN GROW TH AND MARGINS “ We just repor ted one of the most successful years of business development in the Company's histor y, and we are confident that Healthways is on track to grow in all of its current customer markets in 2014.” - John Ballantine, P
Slide 41: Sound Familiar?
SOUND FAMILIAR? “Demand for our solutions has put us firmly on the path to re- establishing a consistent record of profitable growth. In fact, we expect the contracts signed in 2011 and 2012 to produce meaningful absolute 2013 revenue growth for the first time since 2008. Fur ther, we expect rising
Slide 42: It Should Sound Very Familiar
IT SHOULD SOUND VERY FAMILIAR “ O n e o f o u r c o r e m e s s a g e s e n t e r i n g 2 011 w a s t h a t d e s p i te t h e c h a l l e n g e s p o s e d by t h i s d i s r u p t i o n , w e ex p e c ted t h e i m m e d i a te a n d n e a r- term o p p o r t u n i t i e s t h a t t h i s t r a n
Slide 43: Is This What Strong Business Development Looks Like?
IS THIS WHAT STRONG “BUSINESS DEVELOPMENT” LOOKS LIKE? 2014 consensus EPS revision history $1.60 $1.40 $1.20 $1.00 $0.80 $0.60 $0.40 $0.20 $0.00 Apr-10 Jun-10 Aug-10 Oct-10 Dec-10 Feb-11 Apr-11 Jun-11 Aug-11 Oct-11 Dec-11 Feb-12 Apr-12 Jun-12 Aug-12 Oct-12 Dec-12 Feb-13 Apr-13 Jun-13 Aug-13 Oct-13
Slide 44: Management Has Never Met Its Initial Margin Guidance Given to Investors
MANAGEMENT HAS NEVER MET ITS INITIAL MARGIN GUIDANCE GIVEN TO INVESTORS Met initial margin guidance? N/A NO N/A NO NO NO NO ?? YEAR 2007 2008 2009 2010 2011 2012 2013 2014 FY end Aug-07 Aug-08 Dec-09 Dec-10 Dec-11 Dec-12 Dec-13 Dec-14 INITIAL GUIDANCE Date of guidance 10/17/06 10/17/07 2/5/09 2/16/1
Slide 45: Part V: Challenging the Incumbent Board
PART V: CHALLENGING THE INCUMBENT BOARD
Slide 46: The Founder's Resignation Letter Illustrates the Need for Change
WE BELIEVE THE FOUNDER’S RESIGNATION LETTER ILLUSTRATES THE NEED FOR CHANGE Dear John, I t i s w i t h g r e a t r e g r e t t h a t I r e s i g n f r o m t h e B o a r d o f D i r e c t o r s o f H e a l t h w ay s , I n c e f f e c t i v e i m m e d i a te l y. Over the last 3 years, I have tried
Slide 47: The Board's Support of the Status Quo Makes No Sense
WE BELIEVE THE BOARD’S SUPPORT OF THE “STATUS QUO” MAKES NO SENSE Healthways’ Board has inexplicably maintained its support for the strategy and management team currently in place: “We remain confident that this Board has developed the best strategy to move the Company forward and continue to build
Slide 48: The Company's Nominees Have No Relevant Healthcare Experience
THE COMPANY’S NOMINEES HAVE NO RELEVANT HEALTHCARE EXPERIENCE North Tide Slate Mac Crawford Brad Karro Paul Keckley Conan Laughlin Relevant Former Chairman, CVS Executive VP at Former Executive Founder and Portfolio Healthcare / Caremark Caremark 1998-2007 Director of the Deloitte Manager of
Slide 49: There Is a Deficiency of Relevant Healthcare Experience
WE BELIEVE THERE IS A DEFICIENCY OF RELEVANT HEALTHCARE EXPERIENCE Public Board experience Name Position Director since Age Relevant healthcare experience other than Healthways John Ballantine Director, Chairman 2003 67 None Portland General Electric Co.; First Oak Brook Bancshares; Enron Ben Leedle
Slide 50: Management and Board Ownership Is Minimal
MANAGEMENT AND BOARD OWNERSHIP IS MINIMAL Healthways’ management and Board own less than 2% of the shares outstanding; Tom Cigarran was the only member of the Board with any meaningful ownership (~1%) prior to his resignation Board Members and Total % Shares Executive Officers Title Shares Owned Out
Slide 51: Part VI: Challenging the Statement: We Believe North Tide Would Derail Momentum
PART VI: CHALLENGING THE STATEMENT: “WE BELIEVE NORTH TIDE WOULD DERAIL MOMENTUM”
Slide 52: North Tide Does Not Understand Our Business
“NORTH TIDE DOES NOT UNDERSTAND OUR BUSINESS” I t i s t r u e . We d o n o t u n d e r s t a n d t h e b u s in e s s e c o n o m i c s o f G a l l u p , B l u e Z o n e s , M e Yo u H e a l t h , D a v e R a m s ey, I n n e r g y, o r O r n i s h . B u t h o w c a n w e ? All shareholders deser
Slide 53: North Tide Does Not Understand Our Business (Cont'd)
“NORTH TIDE DOES NOT UNDERSTAND OUR BUSINESS” (CONT’D) The International business generated $3.3mm of EBITDA in 2013 – thank you for the disclosure! We had previously assumed the International business generated $0 EBITDA The new EBITDA disclosure now implies that the non-Silver Sneakers busin
Slide 54: We Believe These Statements Regarding Our Nominees Are False and Misleading
WE BELIEVE THESE STATEMENTS REGARDING OUR NOMINEES ARE FALSE AND MISLEADING O u r n o m i n e e s h a v e H I G H LY R E L E VA N T h e a l t h c a r e e x p e r i e n c e We u n d e r s t a n d t h a t t h e b u s i n e s s m o d e l i s b r o ke n , w e u n d e r s t a n d t h e h e a l t h c
Slide 55: Healthways' Claims That Its Stock Has Outperformed Are Misleading
HEALTHWAYS’ CLAIMS THAT ITS STOCK HAS OUTPERFORMED ARE MISLEADING This is only true if we cherry pick a very recent time period and include the stock’s outperformance after North Tide Capital filed its 13-D. North Tide Capital files initial 13D on 10/28/2013 55 Source: Page 2, Healthways investor pr
Slide 56: Contrary to the Company's Misleading Statements
CONTRARY TO THE COMPANY’S MISLEADING STATEMENTS… We have nominated a slate o f highly qualified candidates who would bring a n outstanding record of shareholder value creation, operating experience and investment performance in the h e a l t h c a r e i n d u s t r y. E d w i n “ M a c ” C r a w f
Slide 57: Mac Crawford's Record of Value Creation at Caremark Speaks for Itself
WE BELIEVE MAC CRAWFORD’S RECORD OF VALUE CREATION AT CAREMARK SPEAKS FOR ITSELF +516% +52% +47% Source: Bloomberg total shareholder return analysis assuming all dividends reinvested. Note: S&P 500 Healthcare index Bloomberg ticker is S5HLTH. Mac Crawford was CEO of Caremark 3/18/1998-3/22/2007 when
Slide 58: Analysts Agree That Recent Stock Performance Is Due to Our Involvement
ANALYSTS AGREE THAT HEALTHWAYS’ RECENT STOCK PERFORMANCE IS DUE TO OUR INVOLVEMENT “ N e a r- t e r m , t h e w o r s t c a s e f o r t h e s to c k i s l i ke l y t h e r e - e l e c t i o n o f t h e i n c u m b e n t d i r e c t o r s — T h e f u n d a m e n t a l s a t H e a l t h w ay s h a ve
Slide 59: Part VII: Valuing Silver Sneakers
PART VII: VALUING SILVER SNEAKERS 59
Slide 60: Silver Sneakers: A Brief Overview
SILVER SNEAKERS A BRIEF OVERVIEW W h a t i s S i l v e r S n e a ker s ? Silver Sneakers is essentially an affinity marketing program designed to get seniors to live a more active and fit lifestyle; roughly 11MM seniors are enrolled or eligible to be enrolled in Silver Sneakers today H e a l t h
Slide 61: Silver Sneakers: The Economics of the Business
SILVER SNEAKERS THE ECONOMICS OF THE BUSINESS We c o n d u c te d a n i n - d e p t h a n a l y s i s t o b e t te r u n d e r s t a n d t h e e c o n o m i c s o f t h e S i l ve r S n e a k e r s b u s i n e s s , i n c l u d i n g c o nv e r s a t i o n s w i t h h e a l t h p l a n s a n d a s u
Slide 62: Silver Sneakers: The Value to Healthways Shareholders
SILVER SNEAKERS THE VALUE TO HEALTHWAYS SHAREHOLDERS At a 10x EBITDA multiple, Silver Sneaker s could be wor th $23/share: (1) Silver Sneakers Revenue $291,845,400 Silver Sneakers gyms (2) 15,000 (3) x Avg payment to gym, per month $688 x months 12 - Estimated cost of gyms, annually $123,795,000 - A
Slide 63: Silver Sneakers: Final Thoughts
SILVER SNEAKERS FINAL THOUGHTS Healthways’ management and the Board have provided minimal disclosure to help investors eva luate the Silver Sneaker s business, and therefore we have had to m ake a number of assumptions to bu ild the “cost” side of the model We believe that on balance our assumpt
Slide 64: Appendix: The North Tide Slate
APPENDIX: THE NORTH TIDE SLATE 64
Slide 65: Edwin "Mac" Crawford
EDWIN “MAC” CRAWFORD E d w i n “ M a c ” C r a w f o r d m o s t r e c e n t l y s e r v e d a s C h a i r m a n o f C V S C a r e m a r k , a Fo r t u n e 2 0 c o m p a ny f o r m e d by t h e 2 0 07 m e r g e r o f C V S a n d C a r e m a r k R x . Fro m 1 9 9 8 - 2 0 07 , M r. C r a w f o r d w a
Slide 66: Bradley S. Karro
BRADLEY S. KARRO B r a d l ey S . K a r r o i s a p r i n c i p a l o f H i l l c o t e A d v i s o r s , a f i r m f o c u s e d o n i n v e s t i n g i n a n d r e s t r u c t u r i n g h e a l t h c a r e c o m p a n i e s . P r i o r to f o u n d i n g H i l l c o t e , M r. K a r r o h e l d a
Slide 67: Paul H. Keckley
PAUL H. KECKLEY P a u l H . Kec k l e y i s t h e E d i t o r o f T h e Kec k l ey R e p o r t a n d a n exper t o n h e a l t h i n d u s t r y t r e n d s a n d U . S . h e a l t h s y s t e m r e f o r m . I n h i s t h i r t y - f i v e y e a r h e a l t h i n d u s t r y c a r e e r, D r. Kec k
Slide 68: Conan J. Laughlin
CONAN J. LAUGHLIN C o n a n J . L a u g h l i n i s t h e Fo u n d e r, Po r t fo l i o M a n a g e r, a n d M a n a g i n g M e m b e r o f N o r t h T i d e C a p i t a l L L C , a B o s t o n - b a s e d i n v e s t m e n t f i r m w i t h over $ 1 b i l l i o n i n a s s e t s u n d e r m a n a
Slide 69: Vote FOR the BLUE Proxy Card
VOTE FOR THE BLUE PROXY CARD North Tide Capital urges shareholders to enhance the Healthways Board and restore credibility at the Company by voting the BLUE Proxy Card to elect North Tide's extremely qualified and experienced Director candidates -- Edwin “Mac” Crawford, Bradley S. Karro, Paul H. Kec